Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sichuan Kelun Pharmaceutical Co Ltd.

https://en.kelun.com/

Latest From Sichuan Kelun Pharmaceutical Co Ltd.

China Biotech Interview: BeiGene Co-Founder Wang Eyes Next Big Things

BeiGene co-founder and chair of the major global biotech's Scientific Advisory Board, Dr. Xiaodong Wang, sits down with Scrip in an exclusive audio interview to shed light on the rapid rise of China's biotech innovation, the country's role in BeiGene's global strategy and the next big things to watch.

China Business Strategies

J.P. Morgan: China Inc. Being Hotly Pursued Amid Rising Innovation, Upbeat Sentiment

After years of laying the foundations, China Biotech Inc. is being pursued by multinationals looking for innovative candidates to commercialize in both China and globally, executives and deals from the just concluded J.P Morgan Global Healthcare Conference show.

China Deals

Merck Points To Antibody-Drug Conjugate Potential During Another Growth Quarter

Keytruda brought in its usual stacks of cash, but Merck’s Q3 earnings call focused largely on a recent alliance with Daiichi Sankyo and the pharma’s growing emphasis on cancer ADCs.

Sales & Earnings Business Strategies

ADCs Propel China Oncology Innovation But PD-1s Still Cast Shadow

Among the newer modalities to tackle cancer, antibody-drug conjugates are fast emerging to rival targeted antibodies and China is fast emerging as a world class source of innovation in the field, as evidenced by a string of recent deals.

Asia Pacific China
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Nutraceuticals
    • Vaccines
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
      • Antibodies
    • Drug Discovery Technologies
      • Molecular Diversity
        • Natural Products
  • Other Names / Subsidiaries
    • Guangxi Kelun Pharmaceutical Co Ltd
    • Hunan Kelun Pharmaceutical Co Ltd
    • Hubei Kelun Pharmaceutical Co Ltd
    • Kelun Pharmaceutical Group
    • KLUS Pharma Inc
    • Shandong Kelun Pharmaceutical Co Ltd
    • Sichuan Kelun Pharmaceutical Research Co Ltd
    • Suzhou Kelun Pharmaceutical Research Co Ltd
    • Sichuan Xindi Pharmaceutical Chemicals Co Ltd
UsernamePublicRestriction

Register